US spent millions funding research on COVID-19 drug, but doesn’t hold patents: GAO,

Between 2013 and 2020, U.S. agencies spent $162 million to study the drug for various viruses, including clinical trials for Ebola and COVID-19, the …, Between 2013 and 2020, U.S. agencies spent $162 million to study the drug for various viruses, including clinical trials for Ebola and COVID-19, the …, Read More

Scroll to Top